Caris Life Sciences, Inc. Common Stock (CAI) is a publicly traded Healthcare sector company. As of September 13, 2026, CAI trades at $24.30 with a market cap of $6.88B and a P/E ratio of 14.29. CAI moved +1.23% today. Year to date, CAI is -10.91%; over the trailing twelve months it is -28.85%. Its 52-week range spans $14.19 to $42.50. Analyst consensus is strong buy with an average price target of $26.29. Rallies surfaces CAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CAI combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $24.30 |
| Market Cap | $6.88B |
| P/E Ratio | 14.29 |
| EPS | $1.70 |
| Dividend Yield | 0.30% |
| 52-Week High | $42.50 |
| 52-Week Low | $14.19 |
| Volume | 1.56M |
| Avg Volume | 0 |
| Revenue (TTM) | $989.61M |
| Net Income | $105.14M |
| Gross Margin | 0.00% |
8 analysts cover CAI: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.29.